Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Seliger

Showing results (211-220 of 304) with videos related to

Pageof 31
Sort By:
Cancers|January 12, 2021
Altered Spatial Composition of the Immune Cell Repertoire in Association to CD34<sup>+</sup> Blasts in Myelodysplastic Syndromes and Secondary Acute Myeloid LeukemiaMarcus Bauer, Christoforos Vaxevanis, Haifa Kathrin Al-Ali, et al.
Clinical and Translational Medicine|January 31, 2023
MicroRNAs affecting the susceptibility of melanoma cells to CD8<sup>+</sup> T cell-mediated cytolysisAntonino A Pane, Theresa Kordaß, Agnes Hotz-Wagenblatt, et al.
Oncoimmunology|September 14, 2020
Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patientsMaria-Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa, et al.
International Journal of Cancer|May 7, 2002
Long-term freedom from recurrence in 2 stage IV melanoma patients following vaccination with tyrosinase peptidesCarmen Scheibenbogen, Dirk Nagorsen, Barbara Seliger, et al.
Oncoimmunology|March 14, 2024
Prognostic impact of the bone marrow tumor microenvironment, HLA-I and HLA-Ib expression in MDS and CMML progression to sAMLMarcus Bauer, Nadja Jäkel, Andreas Wilfer, et al.
Proteomics|February 24, 2009
Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinomaBarbara Seliger, Sven P Dressler, Ena Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2017
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscapeLeisha A Emens, Paolo A Ascierto, Phillip K Darcy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
Latent Cytomegalovirus Infection in Rheumatoid Arthritis and Increased Frequencies of Cytolytic LIR-1+CD8+ T CellsKathrin Rothe, Dagmar Quandt, Kristin Schubert, et al.
Cancer Research|June 17, 2006
Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunityHåkan Norell, Mattias Carlsten, Tomas Ohlum, et al.
Molecular Cancer Research : MCR|September 13, 2013
HER-2/neu mediates oncogenic transformation via altered CREB expression and functionAndré Steven, Sandra Leisz, Chiara Massa, et al.
Pageof 31

Showing results (211-220 of 304) with videos related to

Sort By:
Pageof 31
Cancers|January 12, 2021
Altered Spatial Composition of the Immune Cell Repertoire in Association to CD34<sup>+</sup> Blasts in Myelodysplastic Syndromes and Secondary Acute Myeloid LeukemiaMarcus Bauer, Christoforos Vaxevanis, Haifa Kathrin Al-Ali, et al.
Clinical and Translational Medicine|January 31, 2023
MicroRNAs affecting the susceptibility of melanoma cells to CD8<sup>+</sup> T cell-mediated cytolysisAntonino A Pane, Theresa Kordaß, Agnes Hotz-Wagenblatt, et al.
Oncoimmunology|September 14, 2020
Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patientsMaria-Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa, et al.
International Journal of Cancer|May 7, 2002
Long-term freedom from recurrence in 2 stage IV melanoma patients following vaccination with tyrosinase peptidesCarmen Scheibenbogen, Dirk Nagorsen, Barbara Seliger, et al.
Oncoimmunology|March 14, 2024
Prognostic impact of the bone marrow tumor microenvironment, HLA-I and HLA-Ib expression in MDS and CMML progression to sAMLMarcus Bauer, Nadja Jäkel, Andreas Wilfer, et al.
Proteomics|February 24, 2009
Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinomaBarbara Seliger, Sven P Dressler, Ena Wang, et al.
European Journal of Cancer (Oxford, England : 1990)|June 18, 2017
Cancer immunotherapy: Opportunities and challenges in the rapidly evolving clinical landscapeLeisha A Emens, Paolo A Ascierto, Phillip K Darcy, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 29, 2015
Latent Cytomegalovirus Infection in Rheumatoid Arthritis and Increased Frequencies of Cytolytic LIR-1+CD8+ T CellsKathrin Rothe, Dagmar Quandt, Kristin Schubert, et al.
Cancer Research|June 17, 2006
Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunityHåkan Norell, Mattias Carlsten, Tomas Ohlum, et al.
Molecular Cancer Research : MCR|September 13, 2013
HER-2/neu mediates oncogenic transformation via altered CREB expression and functionAndré Steven, Sandra Leisz, Chiara Massa, et al.
Pageof 31